This month Nature Reviews Drug Discovery contains an article about Tufts CSDD Impact Report. Bayer, AstraZeneca, Allergan, Boehringer Ingelheim and Merck turn out to be the speed-demons of pharmaceutical industry.
"These five companies, according to the report "deliver as much as a 17-month speed advantage over average performers"."
The reason is clear why other are so slow.
"Decisions still tend to be made at the highest possible level, which means decision-makers have less insight into what people are working on. Project teams go to the decision-makers fighting for their compounds as much as possible, and are reluctant to give up on their project, in the hope that a project will succeed through perseverance. This makes it easy for projects to run beyond the point where the team knows they are not going to work."
Wow.. What a conclusion… We all knew that already. This is how it works in all industries, and in politics as well.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment